Clinical trial

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

NCT01646827

Study summary

ClinicalTrials.gov

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Aripiprazole IM Depot Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-05-01

PhasePHASE1

Conditions

Schizophreniaverified · MONDO: schizophrenia

Interventions

Aripiprazole IM DepotDRUG

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Mapped research locations

San DiegoCalifornia, United States1 Washington D.C.District of Columbia, United States1 AustinTexas, United States1 Santa AnaCalifornia, United States1 Garden GroveCalifornia, United States1 CerritosCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01646827 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.